FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
The Office of the Assistant Secretary for Health seeks public comments on a proposed threshold for scheduling 7-hydroxymitragynine under the Controlled Substances Act.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
I need the description to create an accurate summary. Please provide the description field for this OMB submission document.
Farm Service Agency seeks public comments on a revised information collection for General Program Administration to verify applicant eligibility, authorized loan use, and government security interests under the Paperwork Reduction Act.
EPA received pesticide product registration applications for new uses of currently registered active ingredients and solicits public comments on the April 2026 compilations.
EPA finalizes hazardous air pollutant emission standards for plywood and composite wood products facilities, setting maximum achievable control technology limits for formaldehyde, acetaldehyde, and other HAP compounds at major source facilities.
FDA seeks 60 days of public comment on information collection requirements for Biologics License Applications under the Paperwork Reduction Act; deadline for comments is 60 days from Federal Register publication.
Federal agencies submit information collection requests to OMB for review and public comment to assess burden on businesses and the public.
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
CDC seeks public comment on a data collection for mChoice, a research study testing tailored provider training and adherence support to improve PrEP uptake among young men who have sex with men in high-priority settings.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
